Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/301% above fair value
$99.94−0.67 (-0.67%)
Close on Nov 20, 2026Market cap $127.84BP/E 24.6Yield 2.84%
Medtronic gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Medtronic's gross profit for the twelve months ending Jul 31, 2026 was $24.41B, up 9.3% year over year. For fiscal 2026 it was $23.64B, up 7.9% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $23.64B in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $23.64B | +7.9% |
| FY2025 | Apr 25, 2025 | $21.91B | +3.6% |
| FY2024 | Apr 26, 2024 | $21.15B | +3.1% |
| FY2023 | Apr 28, 2023 | $20.51B | -4.8% |
| FY2022 | Apr 29, 2022 | $21.54B | +9.7% |
| FY2021 | Apr 30, 2021 | $19.63B | +0.7% |
| FY2020 | Apr 24, 2020 | $19.49B | -8.9% |
| FY2019 | Apr 26, 2019 | $21.40B | +2.4% |
| FY2018 | Apr 27, 2018 | $20.90B | +2.3% |
| FY2017 | Apr 28, 2017 | $20.42B | +3.7% |
| FY2016 | Apr 29, 2016 | $19.69B | +41.1% |
| FY2015 | Apr 24, 2015 | $13.95B | +10.1% |
| FY2014 | Apr 25, 2014 | $12.67B | +1.7% |
| FY2013 | Apr 26, 2013 | $12.46B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $6.34B | +13.7% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $6.41B | +10.9% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $5.76B | +4.4% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $5.90B | +8.1% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $5.58B | +8.2% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $5.78B | +4.2% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $5.51B | +3.9% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $5.46B | +4.5% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $5.15B | +1.6% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $5.55B | -0.4% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $5.31B | +5.3% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $5.22B | +3.4% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $5.07B | +4.5% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $5.57B | +1.2% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $5.04B | -5.0% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $5.05B | -5.6% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $4.86B | -9.9% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $5.50B | -0.7% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $5.30B | +2.9% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $5.35B | +8.3% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $5.39B | +34.7% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $5.54B | +48.2% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $5.15B | -3.1% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $4.94B | -7.0% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $4.00B | -21.9% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $3.73B | -34.1% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $5.32B | +0.7% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $5.31B | +0.6% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $5.13B | -1.0% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $5.66B | -1.4% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $5.28B | +2.0% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $5.28B | +7.1% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $5.18B | +2.8% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $5.75B | +4.9% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $5.18B | +3.2% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $4.93B | -1.8% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $5.04B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $5.48B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $5.02B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $5.02B | – |
See a number that looks wrong?